Data for Comparison of the metabolome and lipidome of wild type and mdx/mTR mice (Study ST000753)

(Analysis AN001181)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2
CL 66:3; [M-2H](2-)@5.74 1.2044 0.7956
CL 70:5; [M-2H](2-)@9.23 1.0774 0.9226
CL 70:7; [M-2H](2-)@5.76 0.9627 1.0373
CL 72:1; [M-2H](2-)@7.71 0.9656 1.0344
CL 72:5; [M-2H](2-)@9.47 1.3568 0.6432
CL 72:6; [M-2H](2-)@9.28 1.1806 0.8194
CL 72:7; [M-2H](2-)@9.12 1.1366 0.8634
CL 72:8; [M-2H](2-)@8.92 1.0852 0.9148
CL 74:10; [M-2H](2-)@8.94 0.5685 1.4315
CL 74:11; [M-2H](2-)@8.76 0.8890 1.1110
CL 74:1; [M-2H](2-)@6.78 1.1869 0.8131
CL 74:3; [M-2H](2-)@6.36 1.1802 0.8198
CL 74:7; [M-2H](2-)@9.36 1.2575 0.7425
CL 74:8; [M-2H](2-)@9.17 1.0366 0.9634
CL 76:10; [M-2H](2-)@9.21 1.0228 0.9772
CL 76:11; [M-2H](2-)@9.01 0.6359 1.3641
CL 76:12; [M-2H](2-)@8.84 0.8088 1.1912
CL 76:9; [M-2H](2-)@9.29 1.2065 0.7935
CL 78:12; [M-2H](2-)@9.07 0.9180 1.0820
CL 78:13; [M-2H](2-)@8.93 0.9741 1.0259
CL 80:15; [M-2H](2-)@8.93 0.8500 1.1500
FFA(16:0) 0.8714 1.1286
FFA(18:0) 0.8988 1.1012
FFA(18:1) 0.7391 1.2609
FFA(18:2) 0.6572 1.3428
FFA(20:0) 0.9284 1.0716
FFA(20:1) 0.8098 1.1902
FFA(20:2) 0.7583 1.2417
FFA(20:4) Arachidonic acid 0.8278 1.1722
FFA(22:0) 0.9729 1.0271
FFA(22:1) 1.0932 0.9068
FFA(22:2) 1.1187 0.8813
FFA(22:3) 1.0869 0.9131
FFA(24:1) 1.2374 0.7626
FFA(24:2) 1.3889 0.6111
FFA(24:3) 1.3275 0.6725
lysoPE 16:0; [M-H]-@1.68 1.0686 0.9314
lysoPE 18:1; [M-H]-@1.83 1.0841 0.9159
lysoPE 18:2; [M-H]-@1.34 0.9483 1.0517
lysoPE 20:4; [M-H]-@1.32 0.9304 1.0696
N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.46 0.8471 1.1529
N-(docosanoyl)-sphing-4-enine; [M-H]-@8.45 0.5811 1.4189
N-(eicosanoyl)-sphing-4-enine; [M-H]-@7.97 0.8449 1.1551
N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.83 1.1032 0.8968
N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.38 0.8684 1.1316
N-(tetracosanoyl)-sphing-4-enine; [M-H]-@8.90 0.8496 1.1504
PC 28:0; [M-Ac-H]-@5.33 0.8178 1.1822
PC 29:0; [M-Ac-H]-@5.69 0.9773 1.0227
PC 30:0; [M-Ac-H]-@6.02 0.8970 1.1030
PC 30:1; [M-Ac-H]-@5.49 0.8487 1.1513
PC 30:2; [M-Ac-H]-@5.03 0.8314 1.1686
PC 31:0; [M-Ac-H]-@6.30 0.8987 1.1013
PC 31:1; [M-Ac-H]-@5.84 0.9974 1.0026
PC 32:1; [M-Ac-H]-@6.12 1.0377 0.9623
PC 32:2; [M-Ac-H]-@5.67 0.8261 1.1739
PC 33:0; [M-Ac-H]-@6.89 0.9945 1.0055
PC 33:1; [M-Ac-H]-@6.50 0.6997 1.3003
PC 33:2; [M-Ac-H]-@6.04 1.2363 0.7637
PC 34:3; [M-Ac-H]-@5.82 1.0298 0.9702
PC 34:4; [M-Ac-H]-@5.55 0.9494 1.0506
PC 35:1; [M-Ac-H]-@7.13 1.1138 0.8862
PC 35:2; [M-Ac-H]-@6.64 1.1696 0.8304
PC 35:3; [M-Ac-H]-@6.18 1.0311 0.9689
PC 36:0; [M-Ac-H]-@7.98 0.9181 1.0819
PC 36:1; [M-Ac-H]-@7.40 1.2594 0.7406
PC 36:4; [M-Ac-H]-@6.15 1.0124 0.9876
PC 36:5; [M-Ac-H]-@5.76 1.1044 0.8956
PC 37:1; [M-Ac-H]-@7.76 0.9317 1.0683
PC 37:2; [M-Ac-H]-@7.29 0.9882 1.0118
PC 37:3; [M-Ac-H]-@6.82 1.0006 0.9994
PC 37:4; [M-Ac-H]-@6.62 0.9550 1.0450
PC 37:7; [M-Ac-H]-@5.33 0.8198 1.1802
PC 38:1; [M-Ac-H]-@8.07 1.1998 0.8002
PC 38:2; [M-Ac-H]-@7.57 0.9904 1.0096
PC 38:3; [M-Ac-H]-@7.23 1.1049 0.8951
PC 39:5; [M-Ac-H]-@6.70 0.9206 1.0794
PC 39:6; [M-Ac-H]-@6.47 0.8245 1.1755
PC 39:7; [M-Ac-H]-@6.03 0.8769 1.1231
PC 39:8; [M-Ac-H]-@5.48 0.6277 1.3723
PC 40:4; [M-Ac-H]-@7.38 1.2094 0.7906
PC 40:7; [M-Ac-H]-@6.18 0.8598 1.1402
PC 41:6; [M-Ac-H]-@7.20 0.8470 1.1530
PC 42:1; [M-Ac-H]-@9.21 0.6840 1.3160
PC 44:12; [M-Ac-H]-@5.66 0.5852 1.4148
PE 30:0; [M-H]-@6.10 1.0767 0.9233
PE 30:1; [M-H]-@5.57 1.2536 0.7464
PE 31:1; [M-H]-@5.99 0.8679 1.1321
PE 33:0; [M-H]-@7.07 0.7492 1.2508
PE 33:2; [M-H]-@6.07 1.0439 0.9561
PE 34:2; [M-H]-@6.43 1.0867 0.9133
PE 34:3; [M-H]-@5.96 1.0980 0.9020
PE 34:4; [M-H]-@5.67 1.0377 0.9623
PE 35:2; [M-H]-@6.75 1.2076 0.7924
PE 35:3; [M-H]-@6.28 1.1071 0.8929
PE 35:4; [M-H]-@6.06 0.6595 1.3405
PE 36:0; [M-H]-@7.88 0.9199 1.0801
PE 36:1; [M-H]-@7.46 1.4719 0.5281
PE 36:6; [M-H]-@5.57 0.9061 1.0939
PE 37:1; [M-H]-@7.69 1.1795 0.8205
PE 37:2; [M-H]-@7.31 0.8225 1.1775
PE 37:5; [M-H]-@6.21 1.1544 0.8456
PE 37:6; [M-H]-@5.98 0.9298 1.0702
PE 38:1; [M-H]-@7.95 1.2367 0.7633
PE 38:3; [M-H]-@7.26 0.9601 1.0399
PE 39:4; [M-H]-@7.25 0.9845 1.0155
PE 39:5; [M-H]-@6.79 1.1132 0.8868
PE 39:7; [M-H]-@6.07 0.9202 1.0798
PE 39:8; [M-H]-@5.64 0.7879 1.2121
PE 40:10; [M-H]-@5.12 0.7634 1.2366
PE 40:1; [M-H]-@8.47 1.0360 0.9640
PE 40:2; [M-H]-@8.00 1.0488 0.9512
PE 40:4; [M-H]-@7.44 1.3711 0.6289
PE 40:6; [M-H]-@6.91 0.8148 1.1852
PE 41:6; [M-H]-@7.09 0.8304 1.1696
PE 42:10; [M-H]-@5.73 0.8505 1.1495
PE 42:11; [M-H]-@5.41 0.7524 1.2476
PE 42:1; [M-H]-@8.94 1.0347 0.9653
PE 42:2; [M-H]-@8.48 0.7154 1.2846
PE 42:3; [M-H]-@8.12 1.0151 0.9849
PE 42:9; [M-H]-@6.07 0.9555 1.0445
PE 44:10; [M-H]-@6.36 1.1518 0.8482
PE 44:12; [M-H]-@5.71 0.7419 1.2581
PE 44:7; [M-H]-@7.51 0.7921 1.2079
PG 32:0; [M-H]-@5.75 1.1229 0.8771
PG 32:1; [M-H]-@5.25 1.2060 0.7940
PG 33:0; [M-H]-@6.05 0.9602 1.0398
PG 33:1; [M-H]-@5.56 0.8714 1.1286
PG 34:1; [M-H]-@5.78 1.1452 0.8548
PG 34:2; [M-H]-@5.36 1.1554 0.8446
PG 34:3; [M-H]-@4.97 1.0435 0.9565
PG 35:1; [M-H]-@6.15 1.1424 0.8576
PG 36:0; [M-H]-@6.89 0.9842 1.0158
PG 36:2; [M-H]-@5.84 1.2163 0.7837
PG 36:3; [M-H]-@5.39 1.4500 0.5500
PG 36:4; [M-H]-@4.89 1.1395 0.8605
PG 36:5; [M-H]-@4.31 1.4820 0.5180
PG 38:3; [M-H]-@5.90 1.1617 0.8383
PG 38:4; [M-H]-@6.07 1.3271 0.6729
PG 38:5; [M-H]-@5.52 1.3985 0.6015
PG 38:6; [M-H]-@5.34 0.8467 1.1533
PG 38:7; [M-H]-@4.33 1.5938 0.4062
PG 40:5; [M-H]-@6.03 1.2591 0.7409
PG 40:6; [M-H]-@5.98 0.9945 1.0055
PG 40:7; [M-H]-@5.02 1.5804 0.4196
PG 40:8; [M-H]-@4.67 1.6559 0.3441
PG 42:10; [M-H]-@4.56 1.7107 0.2893
PG 42:9; [M-H]-@4.79 1.6129 0.3871
PG 44:11; [M-H]-@4.77 1.7020 0.2980
PG 44:12; [M-H]-@4.48 1.7021 0.2979
PI 36:2; [M-H]-@5.91 1.3788 0.6212
PI 36:4; [M-H]-@5.25 1.4137 0.5863
PI 38:3; [M-H]-@6.10 1.1873 0.8127
PI 38:4; [M-H]-@5.87 1.0975 0.9025
PI 38:5; [M-H]-@5.33 1.3358 0.6642
PI 40:5; [M-H]-@5.98 1.2412 0.7588
PI 40:6; [M-H]-@5.78 1.1454 0.8546
PI 40:7; [M-H]-@5.26 0.9064 1.0936
plasmenyl-PE 30:0; [M-H]-@6.47 0.8405 1.1595
plasmenyl-PE 32:0; [M-H]-@7.11 0.8860 1.1140
plasmenyl-PE 32:1; [M-H]-@6.58 0.9567 1.0433
plasmenyl-PE 36:1; [M-H]-@7.74 1.0302 0.9698
plasmenyl-PE 36:5; [M-H]-@6.29 1.2689 0.7311
plasmenyl-PE 38:1; [M-H]-@8.24 0.6205 1.3795
plasmenyl-PE 38:2; [M-H]-@7.85 1.0154 0.9846
plasmenyl-PE 38:3; [M-H]-@7.56 1.1813 0.8187
plasmenyl-PE 38:4; [M-H]-@7.22 1.2096 0.7904
plasmenyl-PE 40:4; [M-H]-@7.74 1.1854 0.8146
plasmenyl-PE 42:4; [M-H]-@8.12 0.9223 1.0777
plasmenyl-PE 42:6; [M-H]-@7.76 0.7483 1.2517
PS 38:4; [M-H]-@6.05 1.3308 0.6692
PS 38:6; [M-H]-@5.22 0.9005 1.0995
PS 40:5; [M-H]-@6.04 1.2410 0.7590
PS 40:6; [M-H]-@5.79 1.0239 0.9761
PS 40:7; [M-H]-@5.34 1.2002 0.7998
PS 40:8; [M-H]-@4.90 1.0955 0.9045
PS 40:9; [M-H]-@4.43 1.0010 0.9990
PS 42:10; [M-H]-@4.81 1.1545 0.8455
PS 42:7; [M-H]-@6.02 1.3676 0.6324
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Genotype:mdx/mTR
F2Genotype:WT
  logo